Company DescriptionHealth and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.

How the Company Makes Money

Health and Happiness (H&H) International Holdings Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Breakdown
Income Statement		Total Revenue
13.64B	13.93B	12.78B	11.55B	11.19B	10.93B
	Gross Profit
8.33B	8.47B	7.70B	7.25B	7.19B	7.23B
	EBIT
1.66B	1.83B	1.45B	1.09B	1.86B	1.98B
	EBITDA
1.83B	2.04B	1.87B	1.42B	2.13B	2.18B
	Net Income Common Stockholders
279.63M	581.85M	611.78M	508.48M	1.14B	1.01B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.73B	1.45B	2.30B	2.40B	1.83B	2.22B
	Total Assets
1.90B	20.04B	20.96B	20.28B	17.22B	15.86B
	Total Debt
0.00	9.22B	9.67B	9.48B	6.17B	6.04B
	Net Debt
-1.73B	7.86B	7.37B	7.08B	4.34B	3.82B
	Total Liabilities
242.11M	13.75B	14.82B	14.40B	11.02B	10.27B
	Stockholders Equity
1.66B	6.30B	6.14B	5.89B	6.20B	5.59B
Cash Flow		Free Cash Flow
2.08B	1.01B	1.37B	1.78B	1.43B	1.31B
	Operating Cash Flow
2.13B	1.10B	1.47B	1.89B	1.53B	1.44B
	Investing Cash Flow
-24.37M	-52.07M	-104.88M	-4.01B	-1.24B	-277.19M
	Financing Cash Flow
-1.88B	-1.99B	-1.49B	2.77B	-687.68M	-869.12M

Health and Happiness (H&H) International Holdings Peers Comparison

Overall Rating

UnderperformOutperform

Sector (54)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BTSDF		$1.01B	20.91	-0.91%	3.84%	―	―
Sector *	54 Neutral	$5.31B	3.29	-45.39%	2.79%	16.77%	-0.07%
VTSYF		$1.27B	80.54	4.00%	1.10%	―	―
1579	73 Outperform	HK$13.64B	17.01	15.77%	5.24%	4.68%	-14.34%
1475	71 Outperform	HK$7.31B	37.84	5.15%	2.26%	3.95%	-42.81%
1717	66 Neutral	HK$3.49B	13.64	4.14%	2.55%	-1.56%	30.87%
9676	57 Neutral	HK$7.45B	29.12		0.56%	―	―

* Healthcare Sector Average

Performance Comparison

BTSDF

Health and Happiness (H&H) International Holdings

1.16

-0.14

-10.77%

VTSYF

Vitasoy International Holdings

1.20

0.35

41.18%

HK:1475

Nissin Foods Co., Ltd.

7.00

2.26

47.68%

HK:1579

Yihai International Holding Ltd.

14.06

0.58

4.30%

HK:1717

Ausnutria Dairy Corp. Ltd.

1.96

-0.24

-10.91%

HK:9676

Shiyue Daotian Group Co., Ltd Class H

6.04

-14.63

-70.78%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.